Kam R, Chen J, Blümcke I, Normann S, Fassunke J, Elger C E, Schramm J, Wiestler O D, Becker A J
Department of Neuropathology, University of Bonn Medical Center, Bonn, Germany.
Neuropathol Appl Neurobiol. 2004 Jun;30(3):225-32. doi: 10.1046/j.0305-1846.2004.00526.x.
Focal epilepsies in young patients are frequently associated with differentiated glioneuronal tumours. Dysplastic neurones represent a characteristic neuropathological feature of gangliogliomas, the most common entity encountered in this group. Here, we have analysed two major components of the reelin pathway involved in neuronal migration and cortical development, that is, p35 and disabled-1 (dab1), in gangliogliomas. Genomic structures of human dab1 and p35 were identified 'in silico' using the HTGS databank, NCBI BLAST 2.1. DNA sequence analysis was carried out in gangliogliomas obtained from 29 epilepsy patients vs. peripheral blood DNA from non-affected control individuals (n = 100). Gene expression of dab1 and p35 was determined by real-time RT-PCR (reverse transcriptase polymerase chain reaction) in gangliogliomas (n = 14) vs. non-neoplastic central nervous system tissue (n = 20). The human dab1 gene contains 13 coding exons and is located on chromosome 1p31-32. A single coding exon constitutes the human p35 gene, which is located on chromosome 17q11.2. A novel homologueous genomic region on chromosome 2 has to be taken into account for future studies on p35. One ganglioglioma patient showed a unique polymorphism in the p35 gene. The single base exchange (C to A) at nucleotide 904 of the p35 cDNA (GenBank X80343, start ATG, codon 302) results in a leucine-isoleucine amino acid substitution. No mutations of the dab1 and p35 genes in gangliogliomas were observed. However, significantly lower levels of dab1 and p35 gene transcripts were detected in gangliogliomas compared to controls (dab1 28.24%, t-test P < 0.001; p35 21.28%, t-test P < 0.001, in gangliogliomas vs. controls). Our data suggest that mutational events of dab1 and p35 are not involved in the molecular pathogenesis of gangliogliomas. A potential functional role of these developmentally regulated genes for the formation of epileptogenic glioneuronal lesions remains to be elucidated.
年轻患者的局灶性癫痫常与分化型神经胶质神经元肿瘤相关。发育异常的神经元是神经节胶质瘤(该组中最常见的实体)的特征性神经病理学特征。在此,我们分析了参与神经元迁移和皮质发育的reelin通路的两个主要成分,即p35和失能-1(dab1)在神经节胶质瘤中的情况。利用高通量基因组序列数据库(HTGS)数据库、NCBI BLAST 2.1 “电子克隆” 鉴定了人类dab1和p35的基因组结构。对29例癫痫患者的神经节胶质瘤与未受影响的对照个体(n = 100)的外周血DNA进行了DNA序列分析。通过实时逆转录聚合酶链反应(RT-PCR)测定了14例神经节胶质瘤与20例非肿瘤性中枢神经系统组织中dab1和p35的基因表达。人类dab1基因包含13个编码外显子,位于1号染色体p31 - 32区域。人类p35基因由单个编码外显子组成,位于17号染色体q11.2区域。在未来对p35的研究中必须考虑2号染色体上一个新的同源基因组区域。一名神经节胶质瘤患者在p35基因中表现出独特的多态性。p35 cDNA(GenBank X80343,起始密码子ATG,密码子302)第904位核苷酸的单碱基交换(C到A)导致亮氨酸 - 异亮氨酸氨基酸替换。在神经节胶质瘤中未观察到dab1和p35基因的突变。然而,与对照组相比,在神经节胶质瘤中检测到dab1和p35基因转录本水平显著降低(dab1为28.24%,t检验P < 0.001;p35为21.28%,t检验P < 0.001,神经节胶质瘤与对照组相比)。我们的数据表明,dab1和p35的突变事件不参与神经节胶质瘤的分子发病机制。这些发育调控基因在致痫性神经胶质神经元病变形成中的潜在功能作用仍有待阐明。